Tumor necrosis factor-a (TNF-a), one of the major stressinduced proinflammatory cytokines, is upregulated in the heart after tissue injury 1, 2 , and its sustained expression can contribute to the development of heart failure 1, 3, 4 . Whether TNF-a also exerts cytoprotective effects in heart failure is not known. Here we provide evidence for a cardioprotective function of TNF-a in a genetic heart failure model, desmindeficient mice. The cardioprotective effects of TNF-a are a consequence of nuclear factor-kB (NF-kB)-mediated ectopic expression in cardiomyocytes of keratin 8 (K8) and keratin 18 (K18), two epithelial-specific intermediate filament proteins 5, 6 . In cardiomyocytes, K8 and K18 (K8/K18) formed an alternative cytoskeletal network that localized mainly at intercalated discs (IDs) and conferred cardioprotection by maintaining normal ID structure and mitochondrial integrity and function. Ectopic induction of K8/K18 expression in cardiomyocytes also occurred in other genetic and experimental models of heart failure. Loss of the K8/K18 network resulted in a maladaptive cardiac phenotype following transverse aortic constriction. In human failing myocardium, where TNF-a expression is upregulated 2 , K8/K18 were also ectopically expressed and localized primarily at IDs, which did not contain detectable amounts of desmin. Thus, TNF-a-and NF-kB-mediated formation of an alternative, stress-induced intermediate filament cytoskeleton has cardioprotective function in mice and potentially in humans.
The role of the pleiotropic intercellular cytokine TNF-α in heart pathophysiology has been considerably debated in the scientific community 7 . Although TNF-α is not constitutively expressed in the heart 8 , it is rapidly and consistently expressed in response to various forms of myocardial injury as part of an intrinsic cardiac response system 1 .
Accumulating data from various experimental models have established that TNF-α engenders deleterious effects in myocardial structure and function, which mimic the characteristic phenotype of heart failure 1, 3, 4 . Less is known with respect to possible beneficial effects of TNF-α in the heart 7, 9, 10 . Uncovering the mechanisms of both the beneficial and deleterious effects of TNF-α signaling may help explain the failure of anti-TNF-α treatment in clinical trials for heart failure 11 and may allow for the development of more efficient therapeutic approaches for this fatal human disease.
We previously characterized TNF-α-mediated detrimental effects in the heart using MHCsTNFα mice, in which the α-myosin heavy chain promoter drives cardiac-specific overexpression of TNF-α (hereafter called Tnf Myh6 mice) 3, 12 . We showed that desmin, a muscle-specific intermediate filament (IF) protein, is a major target in TNF-α-induced cardiomyopathy 13, 14 . Specifically, desmin, cleaved by TNF-α-induced caspase-6, loses its proper ID localization and forms dense intracellular aggregates. In Tnf Myh6 mice expressing a caspase cleavage-resistant desmin mutant (D263E), cardiac myocyte apoptosis is attenuated, left ventricular (LV) wall thinning is prevented and cardiac function is improved, revealing an important role for desmin cleavage in the development of dilated cardiomyopathy and heart failure.
A plethora of mutations in the gene that encodes desmin are associated with desmin-related myopathies 14, 15 , indicating the relevance of desmin to human heart disease. A milestone in the study of the intermediate filament cytoskeleton in the myocardium was the generation of desmin-deficient (Des −/− ) mice 16 , a widely used model of dilated cardiomyopathy (DCM) and heart failure, characterized by myocardial necrosis, early inflammation and extensive fibrosis and calcification [16] [17] [18] .
To further investigate the role of desmin in TNF-α-mediated cardiomyopathy, we crossed the above described heart failure models, Tnf Myh6 and Des −/− mice, to generate Des −/− mice with cardiac-specific TNF-α overexpression. Unexpectedly, these mice showed considerable rescue of the extensive myocardial degeneration typical of Des −/− mice. The extensive fibrotic lesions (termed 'replacement fibrosis') and calcified areas characteristic of Des −/− pathology 16, 17 were totally absent in Tnf Myh6 ;Des −/− myocardium (Fig. 1a) . There was also a marked reduction of ventricular-wall thinning and dilation (Fig. 1a) , Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18 verified by echocardiographic analysis ( Supplementary Fig. 1 and Supplementary Table 1a) . Myocardial necrosis and inflammation, both typical of Des −/− hearts, were significantly attenuated in Tnf Myh6 ;Des −/− littermates ( Fig. 1b and Supplementary Figs. 2 and 3; P < 0.01). Cardiomyocyte ultrastructural defects, particularly in mitochondrial morphology and distribution and secondarily in myofibril integrity, are hallmarks of desmin-deficient cardiomyopathy 19 . Transmission electron microscopy of cardiac sections and isolated mitochondria demonstrated that the overall ultrastructure of Tnf Myh6 ;Des −/− cardiomyocytes was considerably improved compared with Des −/− myocardium (Fig. 1c,e and Supplementary Fig. 4e-f) . Specifically, the aberrant matrix fragmentation and abnormal ultrastructure of cristae, characteristic of Des −/− mitochondria 19 , were notably improved in Tnf Myh6 ;Des −/− mitochondrial preparations ( Fig. 1e and Supplementary Fig. 5e ). Furthermore, overall cardiac mitochondrial function, which is compromised in Des −/− hearts, was largely rescued upon TNF-α overexpression. Specifically, the prominent decrease in the respiratory function of Des −/− mitochondria, as assessed by measuring oxygen consumption (respiratory control ratio, state III/state IV) in isolated cardiac mitochondria of 3-month-old mice, was significantly improved in Tnf Myh6 ;Des −/− hearts ( Fig. 1d and  Supplementary Fig. 5a ; P < 0.01). This finding is in agreement with rescue of ATP levels (Supplementary Fig. 5b ) and redox status, as analyzed by measuring the reduced and oxidized pools of glutathione and pyridine nucleotides ( Supplementary Fig. 5c-d) . Furthermore, this unexpected attenuation of heart abnormalities in Tnf Myh6 ;Des −/− mice was associated with a significant improvement in cardiac function, including fractional shortening (FS) (Tnf Myh6 ;Des −/− versus Des −/− : 37.7% versus 34.6% in 3-month-old and 35.7% versus 27.0% in 6-month-old mice, respectively; P < 0.001) (Fig. 1f, Supplementary  Fig. 1 and Supplementary Table 1a) .
To understand the mechanism by which TNF-α overexpression rescues Des −/− myocardium, we analyzed changes in the transcriptome of Tnf Myh6 ;Des −/− compared with Des −/− hearts by performing wholegenome microarray analysis. Among 646 genes with significantly altered expression (fold change (FC) > ± 2, P < 0.05), 206 were downregulated and 440 were upregulated in Tnf Myh6 ;Des −/− compared with Des −/− hearts (Supplementary Fig. 3 ). Data meta-analysis revealed that the upregulated genes (FC >2) are mainly implicated in cell death and cellto-cell signaling and interaction responses (Supplementary Fig. 3c ). In contrast, the most prominent downregulation was observed for genes associated with inflammation-immunity-and tissue remodelingrelated processes (Supplementary Fig. 3c , Supplementary Table 2 and Supplementary Data Set), reflecting an amelioration of leukocyte infiltration and inflammation in Tnf Myh6 ;Des −/− hearts ( Supplementary  Fig. 2 ), in contrast to Des −/− hearts 17 .
Notably, among the most pronounced and unexpected changes in gene expression was the high-level ectopic induction of the Krt8 
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; D e s -/-T n f M y h 6 f Figure 1 TNF-α overexpression rescues myocardial degeneration, ultrastructural abnormalities, mitochondrial defects and cardiac dysfunction caused by desmin deficiency. (a) Representative images of whole-heart morphology and corresponding histology by Masson's trichrome staining of cardiac sections of 3-month-old mice. The images are representative of n = 4 per genotype. Calcification is indicated by an asterisk. In histological sections, fibrotic areas with collagen deposition in Des −/− hearts are stained in dark green. Scale bars, 1 mm. (b) Detection of necrotic areas by Evans blue dye staining (red fluorescence) of cryosections from hearts of 4-month-old mice. The images are representative of n = 3 per genotype. Scale bars, 100 µm. (c) Electron microscopic analysis of the myocardium of 3-month-old mice. The images are representative of n = 3 per genotype. Scale bars, 1 µm. (d) Left, oxygen consumption levels of isolated cardiac mitochondria from 3-month-old mice, measured with a Clark-type oxygen electrode and presented as the respiratory control ratio (state III/state IV). Right, representative mitochondrial respiration traces of heart mitochondria from mice of the indicated genotypes. 150 µg of mitochondria (arrow, Mito) were added in the presence of 5 mM glutamate and 2.5 mM malate. 400 µM ADP was added after 3 min (state III) and 1 µM oligomycin after 6 min (state IV), as indicated by arrows (for sample sizes, see Supplementary Fig. 5a ). Two-sided P values: **P < 0.01 (one-way analysis of variance (ANOVA), Bonferroni-Dunn post hoc test). (e) Transmission electron microscopy of isolated cardiac mitochondria. The images are representative of n = 4 per genotype. Class I (arrows) and class IV (arrowheads) mitochondria are depicted (as explained in Supplementary Fig. 5 ). Scale bars, 1 µm. (f) Fractional shortening percentage (FS %) analyzed by two-dimensional-directed M-mode echocardiography in 3-month-old and 6-month-old mice. For sample sizes, see Supplementary Table 1a . All data are presented as mean ± s.e.m. Two-sided P values: **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way analysis of variance (ANOVA), Bonferroni-Dunn post hoc test).
npg l e t t e r s 1 0 7 8 VOLUME 21 | NUMBER 9 | SEPTEMBER 2015 nature medicine keratin pair is normally expressed in the simple epithelium of various organs (such as liver, kidney, mammary gland, etc.) 5, 20 and has not previously been detected in the adult myocardium or in other muscle types 21, 22 (Fig. 2b) . We also confirmed expression of the Krt8 and Krt18 genes at the protein level (Fig. 2b) . Furthermore, we found by immunofluorescence microscopy that K8/K18 were expressed throughout the myocardium of TNF-α-overexpressing mice (Fig. 2g) . This expression pattern was also evident in hearts from neonatal Tnf Myh6 ;Des −/− mice ( Supplementary  Fig. 4g ) and persisted as the mice aged, until at least 12 months of age (data not shown). Control WT myocardium was negative for K8/K18 expression, both by western blot analysis (Fig. 2b) and immunofluorescence microscopy ( Fig. 2g) , as expected from previous studies 21, 22 . K8/K18 expression was detectable in Des −/− myocardium, although less evident than in Tnf Myh6 ;Des −/− myocardium, occurring in scattered islets of cardiomyocytes ( Supplementary Fig. 6 ).
To address the mechanism for the ectopic induction of K8/K18 in Tnf Myh6 ;Des −/− myocardium, we explored the potential involvement of NF-κB in the transcriptional induction of the Krt8 and Krt18 genes, given that NF-κB is downstream of TNF-α signaling. Because there is very limited information available on Krt8 and Krt18 gene regulation, we performed a bioinformatics analysis (including use of ENCODE consortium data and a transcription factor binding sites prediction tool, Supplementary Table 3), which revealed several potential regulatory regions in the Krt8/Krt18 locus (Supplementary Fig. 7 ). We performed in vivo cardiac chromatin immunoprecipitation experiments to test whether the p65 subunit of NF-κB binds these regions. We found that p65 binds at least one genomic regulatory locus of each of the two genes (the K8R2P1 region for Krt8 and the K18R1P3 and K18R2P2 regions for Krt18), as well as to an intergenic region of potential regulatory importance (the K8K18R2P2 region) ( Fig. 2c and Supplementary Fig. 7 ). These results imply that NF-κB could be involved in the ectopic activation of both Krt8 and Krt18 gene transcription in Tnf Myh6 ;Des −/− hearts.
We next tested the involvement of NF-κB in the ectopic induction of K8/K18 expression in the heart using an in vivo conditional (tetoff) model of cardiac-specific transgenic expression of constitutively active inhibitor of NF-κB kinase 2 (IKK2) (IKK MyHC mice) 24 . IKK2 is required for activation of canonical NF-κB pathway signaling. In contrast to the control group (single-transgenic mice carrying either the MyHC.tTA or the tetO.IKK2-CA transgene, or WT littermates), IKK MyHC mice showed ectopic expression of K8/K18 in the myocardium ( Fig. 2d and Supplementary Fig. 8a,b) . Induction was evident at both 5 and 12 weeks after doxycycline repressor withdrawal. The early induction is consistent with a direct dependence of K8/K18 ectopic expression on NF-κB activation, given that an overt heart failure phenotype in these mice usually starts to develop at 6-8 weeks after doxycycline withdrawal 24 . Complementary to this IKK MyHC gain-offunction in vivo model, we used a loss-of-function in vivo approach to verify the involvement of NF-κB in the ectopic induction of K8/K18. We crossed Tnf Myh6 mice with mice that have a cardiac-specific NF-κB signaling blockade, conferred by cardiac-specific expression of an IκBα superrepressor (IκBα-3M mice) 25 , to generate Tnf Myh6 3M mice. These mice showed a significant decrease of both Krt8 and Krt18 expression in the heart (by 29% and 41%, respectively, P < 0.05) (Fig. 2e) .
Next, we used luciferase reporter assays to verify the in vivo data implicating NF-κB in the transcriptional regulation of Krt8 and Krt18. In these assays, we used genomic regions 2 kb in length that lie upstream of each of their translation start sites (see Supplementary Fig. 8c ) and include all the regulatory loci as described in Supplementary  Figure 7 . Both Krt8 and Krt18 were significantly responsive to p65 induction (1.91 and 2.08, respectively, fold change relative to the non-induced condition, P < 0.001) (Fig. 2f) . Furthermore, mutations in the NF-κB-binding sites found to bind p65 in vivo ( Fig. 2c and  Supplementary Fig. 7 ) significantly reduced p65-dependent Krt8 and Krt18 induction (by 23% and 40%, respectively, relative to the levels of induction achieved with the WT sequences, P < 0.05) (Fig. 2f and  Supplementary Fig. 8e ). The effect of the NF-κB-binding site mutations on Krt8 and Krt18 regulation was also observed under baseline conditions ( Supplementary Fig. 8d,e) .
Using immunofluorescence microscopy, we found that the ectopic expression of both the K8 and K18 proteins in TNF-α-overexpressing hearts was restricted to cardiomyocytes, where K8 and K18 fully co-localized (Fig. 2h) ; we could not detect K8 and K18 in cardiac fibroblasts (Supplementary Fig. 9 ). In Tnf Myh6 ;Des −/− cardiomyocytes, the 'area composita' (fusion of desmosomes and fasciae adherentes) 26 of the intercalated disc was the major site of localization of the K8/K18 pair (Fig. 2h,i and Supplementary Fig. 4a ). Similarly to the localization of desmin in normal myocardium, K8/K18 co-localized with major components of desmosomes and adherens junctions, such as desmoplakin (DSP) and β-catenin, respectively, at the IDs of Tnf Myh6 ;Des −/− myocardium ( Fig. 2i and Supplementary Fig. 4a ). We did not detect localization of K8/K18 to Z-discs; however, we did observe a sarcoplasmic striated pattern of K8/K18 localization at the M-line level of the myofibrils, extending to the costameres ( Fig. 2h and Supplementary Fig. 4b ). Immunoelectron microscopy further confirmed K8 localization to cardiomyocyte ID plaques and revealed a filamentous organization of the K8/K18 network ( Fig. 2j and Supplementary Fig. 4c ).
Keratins have been linked to several mechanical and nonmechanical cytoprotective functions 6, 27 . K8 and K18 form obligatory heteropolymers that are involved in modulation of signal transduction pathways, protection from cell death, protein targeting and organelle regulation and transport 6, [27] [28] [29] [30] . Furthermore, altered expression, localization and post-translational modification of K8/K18 have been reported to occur in several pathological settings, from liver pathophysiology to cancer 5 . Therefore, we asked whether the highly expressed and specifically localized K8/K18 in Tnf Myh6 ;Des −/− cardiomyocytes could be responsible for the TNF-α-mediated rescue of the myocardial degeneration and dilated phenotype observed in Des −/− mice. To address this issue, we generated Tnf Myh6 ;Des −/− ;Krt18 −/− mice, which represent a K8/K18 deficient model, given that K8 is degraded in the absence of its partner IF 28 .
While the gross morphology of Tnf Myh6 ;Des −/− ;Krt18 −/− hearts appeared similar to that of Tnf Myh6 ;Des −/− hearts, histological sections reveal a more prominent dilated phenotype in Tnf Myh6 ;Des −/− ;Krt18 −/− hearts ( Fig. 3a) , which was verified by echocardiographic analysis (Supplementary Fig. 1 and Supplementary Table 1a) . Additionally, there appeared to be an increased amount of interstitial fibrosis in Tnf Myh6 ;Des −/− ;Krt18 −/− hearts, and areas of replacement fibrosis were occasionally evident (Fig. 3a) , unlike in Tnf Myh6 ;Des −/− myocardium. Echocardiographic data showed a significant reduction in overall cardiac function in Tnf Myh6 ;Des −/− ;Krt18 −/− compared to Tnf Myh6 ;Des −/− mice (FS: 31.6% versus 37.7% in 3-month-old mice and 27.7% versus 35.7% in 6-month-old mice, respectively; P < 0.001) (Fig. 3b, 
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Supplementary Fig. 1 and Supplementary Table 1a) . These results indicate that the cytoprotective action of TNF-α is lost in the absence of K8/K18. Although these data suggest a cardioprotective role for the K8/K18, we did not observe any significant changes in FS (Supplementary Table 1a ; P > 0.05) or histology (data not shown) in Tnf Myh6 ;Krt18 −/− compared to Tnf Myh6 hearts, consistent with the known dominant effect of the defective desmin network in Tnf Myh6 mice 13 . However, lack of K8/K18 in Tnf Myh6 ;Krt18 −/− hearts led to a more dilated phenotype compared to Tnf Myh6 hearts ( Supplementary  Fig. 1 and Supplementary Table 1a), suggesting that K8/K18 may be partially cardioprotective in the Tnf Myh6 model, as well. Krt18 −/− hearts had similar characteristics to WT hearts based on morphological, histological and echocardiographic analyses (Fig. 3a,b) , whereas Des −/− ;Krt18 −/− hearts had similar pathological characteristics to Des −/− hearts, including extensive replacement fibrosis, calcification and myocardial degeneration (data not shown).
One of the important functional roles of keratin IFs stems from their interaction with desmosomes, the intercellular adhesive junctions of epithelial cells. This critical interaction confers stabilization and maintenance of the desmosome structures 31 , proper targeting of desmosomal proteins 30 , subsequent maintenance of surface membrane integrity 32 and facilitation of intercellular mechanical and ionic communication 32 . Complementary to their protein-targeting function, another important role of IFs is organelle modulation, specifically of mitochondria 14, 33, 34 . Evidence for the importance of the IF cytoskeleton in mitochondrial structure and function has been provided by previous studies in Des −/− mice 19, 35 , consistent with the data on mitochondria presented in Figure 1c -e. Additionally, recent data suggest a similar cytoprotective mechanism of K8/K18 (or K8/K19) through effects on mitochondria 29, 36, 37 . Therefore, we hypothesized that the mechanism of protection by K8/K18 in Tnf Myh6 ;Des −/− mice could be through maintenance of mitochondrial, ID and myofibril integrity.
Electron microscopy studies revealed severe ultrastructural defects in Tnf Myh6 ;Des −/− ;Krt18 −/− myocardium. As compared to Tnf Myh6 ;Des −/− myocardium, mitochondria in Tnf Myh6 ;Des −/− ;Krt18 −/− myocardium accumulated, were found in atypical aggregates and were disarranged ( Fig. 3c and Supplementary Fig. 10a ). Myofibril organization in Tnf Myh6 ;Des −/− ; Krt18 −/− myocardium was also defective ( Fig. 3c and Supplementary Fig. 10a ). The mitochondrial abnormalities resembled the characteristic defects in desmin-deficient cardiomyopathy 33 , arguing for a central role of IFs in mitochondrial homeostasis and suggesting that K8/K18 can compensate for the absence of desmin to preserve normal mitochondria. Indeed, partially or totally swollen mitochondria (class III and class IV, see legend of Supplementary Fig. 5 ) were prominent in Tnf Myh6 ;Des −/− ;Krt18 −/− hearts ( Fig. 3c and Supplementary Fig. 5e ). Notably, these ultrastructural abnormalities in the absence of the K8/K18 network were associated with a considerable impairment of mitochondrial functional status, as mitochondrial respiration was severely defective ( Fig. 3d and Supplementary Fig. 5a ). Furthermore, ATP levels ( Supplementary Fig. 5b ) and redox activities ( Supplementary Fig. 5c,d ) were abnormal in Tnf Myh6 ;Des −/− ;Krt18 −/− versus Tnf Myh6 ;Des −/− cardiac mitochondria. These findings support the hypothesis that a mitoprotective effect of the K8/K18 network is a mechanism by which TNF-α mediates cardioprotection in Des −/− myocardium.
Furthermore, the IDs of Tnf Myh6 ;Des −/− ;Krt18 −/− cardiomyocytes were severely abnormal; they were discontinuous and amorphous in appearance as compared to the IDs of WT or Tnf Myh6 ;Des −/− myocardium (Fig. 3f) . Consistent with this finding, critical components of the area composita were mislocalized in Tnf Myh6 ;Des −/− ;Krt18 −/− myocardium, including desmoplakin, plakoglobin and β-catenin ( Fig. 3e  and Supplementary Fig. 10b ). This finding suggests that the proper targeting of these proteins to IDs, or the maintenance of their localization in IDs, is part of the mechanism by which the K8/K18 network compensates for the desmin deficiency in Tnf Myh6 ;Des −/− hearts, consistent with reports on a mechanism by which keratins regulate desmosome maintenance 30, 31 .
A key question raised by our findings is whether the induction of K8/K18 expression observed in TNF-α-overexpressing mice reflects a common response in heart failure. To address this issue, we studied Krt8 and Krt18 expression in the heart in additional, well-established Myh6 ;Des −/− and Des −/− hearts (n = 3 hearts per genotype; n = 3 replicates). Left, heat maps show the log 2 -transformed expression ratios between the genotypes, for each of the three replicates. Each replicate corresponds to one hybridization experiment, as explained in the Online Methods. Right, MvA (log 2 -transformed fold change versus average absolute log 2 -transformed expression) scatter plot (FC > ±2, P < 0.05). Krt8 and Krt18 were among the top three upregulated genes (red boxes and arrows) (unpaired t-test; Benjamini-Hochberg correction). (b) Top, Krt8 and Krt18 expression in hearts of mice of the indicated genotypes relative to WT, as assessed by RT-PCR of total myocardial RNA (n = 6 per genotype, n = 4 replicates, one-way ANOVA, Bonferroni-Dunn post hoc test). The gene encoding β-actin was used as the reference gene. Bottom, K8 and K18 protein levels as assessed by western blots of total myocardial extracts from 3-and 6-month-old mice (n = 4 per genotype). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the loading control. (c) Chromatin immunoprecipitation (ChIP, analysis using anti-p65 antibodies in chromatin samples of Tnf Myh6 ;Des −/− (TD) and WT hearts (n = 3 per genotype, n = 3 biological replicates). K18R1P3, K18R2P2, K8R2P1 and K8K18R2P2 correspond to regulatory regions of Krt8 and Krt18 loci that showed significant enrichment in TD compared to WT samples (two-way ANOVA, BonferroniDunn post hoc test). Neg, a DNA region containing no known NF-κB protein-binding sites and/or regulatory activity. (d) Top, Krt18 expression in IKK MyHC mouse hearts relative to appropriate controls, as assessed by RT-PCR, 5 and 12 weeks after doxycycline withdrawal (n ≥ 6 per group, n = 3 replicates, unpaired t-test). Ribosomal protein L13 (Rpl13) was used as the reference gene. Bottom, immunofluorescence staining for K8 (red) and desmin (Des; green) in cardiac sections of IKK MyHC and control mice, 12 weeks after doxycycline (dox) withdrawal. The images are representative of n = 4 per genotype. Scale bars, 50 µm. (e) Krt8 and Krt18 expression, as assessed by RT-PCR, in the myocardium of 6-week-old Tnf Myh6 3M mice (n = 11) relative to their Tnf Myh6 littermates (n = 6) (n = 3 replicates, unpaired t-test). The gene encoding β-actin was used as the reference gene. (f) Firefly luciferase reporter activity assays using WT (Krt8luc and Krt18luc) and mutated (µ2Krt8luc and µ2Krt18luc) 2-kb regulatory regions of Krt8 and Krt18, upon p65 induction in HEK293 cells. The CMV-p65 plasmid was co-transfected as indicated. Luciferase activity is presented relative to the respective non-induced unmutated reporter. All experiments (n ≥ 8) were normalized to β-galactosidase activity (one-way ANOVA, Bonferroni-Dunn post hoc test). A5198_D  A5228_D  A5229_D  A8019_TD  A8021_TD  A8023_TD  A5198_D  A5228_D  A5229_D  A8019_TD  A8021_TD genetic and experimental models of heart failure. We found that both of these genes were ectopically induced in transgenic hearts with cardiac-specific overexpression of constitutively-active calcineurin (MHC-Cn mice) 38 , a calcium-dependent phosphatase, and in hearts of muscle LIM-only protein-knockout mice (Csrp3 −/− ) 39 (Fig. 4a) . Notably, in both models, K8/K18 had the same protein localization properties as described for TNF-α-overexpressing cardiomyocytes (Fig. 2h,i) , forming a network localized to cardiomyocyte IDs and costameric striations, although expression of K8/18 was lower in these models than in TNF-α-overexpressing cardiomyocytes (Fig. 4a) . Moreover, the K8/K18 network was also detectable in hearts of mice subjected to experimentally induced heart failure. Cardiomyocytes of WT mice subjected to either transverse aortic constriction (TAC) or myocardial infarction (MI) by permanent ligation of the left anterior descending coronary artery exhibited the same pattern of K8/K18 expression as observed in the genetic models of heart failure ( Fig. 4b and Supplementary Fig. 11a-d) . Hearts from WT sham-operated control mice did not express K8/K18. These data provide strong evidence for the global nature of K8/K18 ectopic induction in stressed or failing cardiomyocytes.
In support of the notion that ectopic induction of K8/K18 in the heart is cardioprotective, Krt18 −/− mice exhibited a significant 25% decline in contractile function (decreased fractional shortening and increased end-systolic dimension) as early as 2 weeks after TAC (Fig. 4c,  Supplementary Fig. 11e and Supplementary Table 1b) , as compared to baseline levels (FS of 52.2% and 39.1% at baseline and at 2 weeks after TAC, respectively; P < 0.001). This decline is probably secondary to the failure of Krt18 −/− mice to develop compensatory heart hypertrophy in response to pressure overload stress, in contrast to WT mice, which undergo a hypertrophic response as demonstrated by a significant increase of relative wall thickness ( Fig. 4c ; P < 0.05 at 2 weeks after TAC and P < 0.001 at 4 weeks after TAC, compared to baseline condition). Consistent with the findings shown in Figure 4b , cardiomyocytes in the hearts of WT mice subjected to TAC showed K8/K18 network formation, with its typical ID and striated pattern ( Fig. 4d and Supplementary Fig. 11a-d) .
Finally, we sought to address the relevance of our findings to human heart failure, where TNF-α has been shown to be upregulated 2 . Using cardiac samples from human subjects with end-stage heart failure who underwent heart transplantation, we found that both K8 and K18 proteins were expressed in human failing heart, with variable levels of K8 and K18 ectopic expression among the subjects with heart failure ( Fig. 4e and Supplementary Fig. 12a ). Serum TNF-α levels in subjects with heart failure were significantly higher as compared to those from a normal control group ( Fig. 4f ; P < 0.01), as reported previously 2 . Similarly to our findings in mouse models of heart failure, Table 1a ). Mean ± s.e.m.; two-sided P values: ***P < 0.001, ****P < 0.0001; one-way ANOVA, Bonferroni-Dunn post hoc test. (c) Electron micrograph of a myocardial section from a 3-month-old Tnf Myh6 ;Des −/− ;Krt18 −/− mouse. The image is representative of n = 2 mice. Severe mitochondrial abnormalities, including fragmentation, disorganization and degeneration are shown (arrows), together with abnormal organization of myofibrils. Scale bar, 2 µm. (d) Left, oxygen consumption levels of isolated cardiac mitochondria from 3-month-old mice of the indicated genotypes, measured using a Clark-type oxygen electrode and presented as the respiratory control ratio (state III/state IV). Two-sided P values: **P < 0.01 (one-way ANOVA, Bonferroni-Dunn post hoc test). Right, representative mitochondrial respiration traces of heart mitochondria from mice of the indicated genotypes. 150 µg of mitochondria (arrow, Mito) were added in the presence of 5 mM glutamate and 2.5 mM malate. 400 µM ADP was added after 3 min (state III) and 1 µM oligomycin (Oligo) after 6 min (state IV), as indicated by arrows (for sample sizes, see Supplementary Fig. 5a ). and supporting the clinical importance of our observations, in human failing myocardium, K8/K18 expression occurred specifically in cardiomyocytes and not in cardiac fibroblasts ( Fig. 4g and Supplementary Fig. 9b ), K8 and K18 colocalized in cardiomyocytes ( Fig. 4h and Supplementary Fig. 12c) , and K8/K18 were clearly detected at the IDs where they colocalized with desmosomal ( Fig. 4g ) and adherens junction (data not shown) proteins. We did not detect any K8/K18 expression in cardiomyocytes of healthy human myocardium ( Supplementary Fig. 12b ), in agreement with the literature 21, 22 . Thus, the low levels of K8/K18 detected by western blot analysis of control myocardium (Fig. 4e and Supplementary Fig. 12a ) may correspond to expression of K8/K18 in noncardiomyocyte cells of the epicardium or in endothelial cells of the heart microvasculature. Based on our previous data in mice 13 , we also investigated the characteristics of the desmin network in human heart failure. Notably, we found that desmin protein levels were elevated in myocardium from human subjects with heart failure as compared to healthy myocardium (Fig. 4e) , likely due to the lower degradation rate of aggregated desmin 13 . Furthermore, immunofluorescence microscopy revealed that desmin lost its normal localization to IDs in human heart failure ( Fig. 4i) , in agreement with our findings in mice 13 . Of note, K8/K18 showed more efficient ID localization compared with desmin Table 1b) . Two-sided P values: *P < 0.05, **P < 0.01, ***P < 0.001 relative to BSL; #P < 0.05, ##P < 0.01 relative to WT (top) and to Krt18 −/− (bottom) (two-way ANOVA, Bonferroni-Dunn post hoc test). (d) Co-staining for K8 with α-actinin or β-catenin in cardiac sections of the same WT mice as used in c at 8 weeks after TAC. The images are representative of n = 3 mice per group. Scale bars, 20 µm. (e) Western blot for K8, K18 and desmin in cardiac samples of human subjects (n = 10) with heart failure (HF) (samples #1-#6 are shown here, and samples #7-#10 are shown in Supplementary  Fig. 12a ). Control, a sample from a normal control heart (n = 1). Arrows, desmin cleavage products at 24 and 29 kDa. GAPDH was used as the loading control. For desmin, bottom, non-adjacent lanes from the same western blot were used, as indicated by the vertical line. (f) ELISA for serum TNF-α of the same human subjects with heart failure (n = 8). Shown is FC relative to the control group (n = 10) (unpaired t-test). (g) Co-staining for K18 and desmoplakin (DSP) in a cardiac section from a subject with heart failure (the Heidelberg subject, as described in the Online Methods). The images are representative of n = 3 subjects with heart failure. Scale bar, 30 µm. (h) Co-staining for K8 with K18 (top) or with desmin (bottom) in cardiac sections from the Heidelberg subject. The images are representative of n = 3 subjects with heart failure. Scale bars: top, 30 µm; bottom, 20 µm. (i) Top, co-staining of desmin and DSP in a cardiac section of a control subject. The images are representative of n = 2 control subjects. Bottom, co-staining of desmin and desmoglein-2 (DSG2) in a cardiac section of the #3 subject with heart failure. The images are representative of n = 3 subjects with heart failure. Scale bars, 20 µm. Projection images were used in g-i. Mean ± s.e.m. Two-sided P values: *P < 0.05, **P < 0.01. ( Fig. 4h and Supplementary Fig. 12c) , consistent with our findings in Tnf Myh6 mice (Supplementary Fig. 12d ). This difference could be related to the potential modification of desmin by caspase-6-mediated cleavage, as we previously demonstrated in Tnf Myh6 failing myocardium 13 . Indeed, desmin-cleavage products were evident in myocardium from some of the human subjects with heart failure, but not in control human myocardium (Fig. 4e) . Whereas mislocalization of desmin has been previously reported in Carvajal syndrome 40 , this is the first report to our knowledge of desmin cleavage and mislocalization in human end-stage heart failure.
Collectively, our results demonstrate a new cardioprotective role for TNF-α through ectopic expression of epithelial IF proteins in the heart. We have uncovered a transcriptional reprogramming mechanism by which this cytokine overcomes the normally tissue-restricted expression of K8 and K18, leading to their expression in adult cardiomyocytes. These proteins form obligatory heteropolymers, a prerequisite for the generation of a properly functioning intermediate filament network 5, 6 . We propose that the ability of TNF-α to ectopically activate both genes through NF-κB plays a major role in the cardioprotection conferred by TNF-α and that the K8/K18 network maintains ID integrity and mitochondrial function to compensate for desmin deficiency. These findings should prompt reconsideration of the mechanisms of stress responses and the balance between positive and negative effectors in myocardial biology. They may also provide some insight into the negative results of anti-TNF-α clinical trials for heart failure 11 and into the mechanisms responsible for heart failure development and recovery.
METHoDS
Methods and any associated references are available in the online version of the paper.
Accession codes. The microarray data can be found in the Gene Expression Omnibus (GEO) with accession number GSE56286. 
oNLINE METHoDS
Mice. Transgenic mice (Mus musculus) with targeted cardiac overexpression of TNF-α (MHCsTNFα model, referred as the Tnf Myh6 model in the text, C57BL/6 genetic background) 41 were used for breeding with desmin knockout mice (Des −/− model, 129SV genetic background) 16 for the generation of Tnf Myh6 ;Des −/− mice, as described previously 13 . Mice lacking K18 (Krt18 −/− , Krt18tm1Tmm/J mice, mixed genetic background MF1/129SV/FVB) 28 , were purchased from Jackson Laboratories and were bred for the generation of Des −/− ;Krt18 −/− , Tnf Myh6 ;Krt18 −/− and Tnf Myh6 ;Des −/− ;Krt18 −/− mice. All TNF-α-overexpressing lines used were heterozygous for the transgene, in accordance with previous studies 41 . Tnf Myh6 3M mice were generated by crossing Tnf Myh6 (C57BL/6) with IκBα-3M (C57BL/6) mice, which provide cardiacspecific blockade of NF-κB signaling, as previously described 25 . Age-matched littermates of both sexes were generally used for the analyses, unless otherwise indicated. The age of the mice used in each study is given in the figure legends or elsewhere in the Online Methods section. Mice with the desired genotype were used for the studies, and no method of randomization was necessary. Our experiments did not involve statistical analyses in which a prespecified effect size was used, were generally blinded and the number of animals used in each experiment was sufficient, given that phenotypes were reproducible. IKK MyHC mice have been described previously 24 . In brief, activation of IKK/ NF-κB signaling in cardiomyocytes is achieved using a tet-off system, by crossing mice expressing the tetracycline transactivator (tTA) under the control of the α-myosin heavy chain (MyHC) promoter with mice bearing a tTA-responsive, constitutively active IKK2 (IKK2-CA) allele. Mice were given doxycycline in their drinking water (1 g/L) until adulthood to prevent transgene expression during development; at the age of 6-10 weeks, doxycycline was removed to allow transgene expression. Control mice used in analyses of IKK MyHC mice were either singletransgenic (positive for either the MyHC.tTA or the tetO.IKK2-CA transgene) or wild-type (WT) littermates. IKK MyHC mice were kept under specific pathogenfree conditions in the animal facility of the University of Ulm. All experiments were in accordance with the German animal welfare law and approved by the responsible regional authority (Regierungspräsidium Tübingen).
Calcineurin transgenic mice (MHC-Cn) 38 , which express the constitutively active form of the calcineurin catalytic subunit in the heart under the control of the a-MHC promoter, and muscle LIM protein knockout (Csrp3 −/− ) mice 39 , have previously been described.
Studies on experimental models of heart failure of Figure 4b were performed using 8-week-old WT (C57BL/6 from Jackson Laboratories) mice. Age-matched, sham-operated mice were used as controls. Briefly, TAC surgery was performed by constriction of the transverse aortic arch using a 7-0 silk ligature that was tied around the aorta (27-gauge constriction) between the right brachiocephalic and left common carotid arteries. MI surgery was performed by permanent ligation of the left anterior descending (LAD) coronary artery, using an 8-0 proline suture, for 4-weeks. 8-week-old sham-operated WT C57BL/6 mice were used as control group in this study. The studies using MHC-Cn and Csrp3 −/− mice and mice subjected to TAC or MI were approved by the Cincinnati Children's Research Foundation Institutional Animal Care and Use Committee (IACUC).
For the analysis of mice subjected to TAC, shown in Figure 4c ,d, Supplementary  Figure 11 and Supplementary Table 1b, see the "Transverse aortic constriction" section below. These studies were performed with the approval of the Institutional Animal Care and Use Committee at Washington University School of Medicine. These investigations conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.
Human samples. Human cardiac tissue samples were taken from the left ventricle of the myocardium of diseased subjects with end-stage heart failure in the course of heart transplantation surgery at the Onassis Cardiac Surgery Center (O.C.S.C., Athens, Greece). Specifically, the O.C.S.C. samples were obtained from 10 diseased subjects (average age at operation: 41 years old; male/female ratio: 7/3), that were randomly selected. Additional samples were obtained from one diseased subject from the Department of Cardiac Surgery of the University Hospital Heidelberg, Germany. For all human diseased subjects undergoing orthotopic heart transplantation, informed consent was obtained for the analysis of tissue removed. Human control heart samples (referred as "normal") were taken from a deceased individual (male; 26 years old; cause of death: head and chest injuries) who had not previously been diagnosed with any form of cardiac disease, with the permission of the Forensic Medical Service of Athens, Greece. We included an additional control myocardial tissue sample, which was purchased (cat.# T1234138; Lot# B409106, Biochain Institute, Inc) and which was taken from the left ventricle of an individual who had not previously been diagnosed with any form of cardiac disease (male, 61 years old). Tissue from diseased subjects was obtained at the time of the transplantation surgery and was immediately snap-frozen in liquid nitrogen. Serum samples used for the ELISA analysis (Human TNF-alpha Quantikine HS ELISA kit, R&D Systems) were obtained from the same O.C.S.C. heart failure subjects as described above. Control serum samples from individuals with no diagnosed cardiac, kidney or hepatic failure and with a similar age distribution to the diseased subjects were obtained from the O.C.S.C. and were randomly selected. Investigations and the use of materials conformed to the principles outlined in the Declaration of Helsinki for the use of human tissue or subjects. All procedures were performed in compliance with Greek legislation and O.C.S.C. Ethical Committee regulations.
Echocardiography. M-mode echocardiography was performed as previously described 13 to measure LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), and LV posterior wall thickness at systole (PWTs) and diastole (PWTd); these measurements were used to calculate the ratio of LV radius to PWT (r/h) and the percentage of LV fractional shortening (FS). 3-and 6-month-old mice were examined (both sexes were used, with a similar male/ female ratio in each genotype group); the number of mice for each genotype is presented in Supplementary Table 1a . Mice with the desired genotype and without any type of permanent arrhythmia were used for the analyses (prespecified exclusion criteria). The measurements were carried out by a sonographer who was blinded to mouse genotype. Mice were anesthetized with an intraperitoneal injection of 100 mg/kg ketamine. Echocardiographic experiments were performed using an ultrasound system (Vivid 7; General Electric Healthcare) with a 13-MHz linear transducer. 2D-targeted M-mode imaging was obtained from the short axis view at the level of greatest LV dimension. Images were analyzed using Echopac PC SW 3.1.3 software (General Electric Healthcare). End diastole was determined at the maximal LV diastolic dimension, and end systole was taken at the peak of posterior wall motion. Three beats were averaged for each measurement. The ratio of LV radius to PWT (r/h) and the percentage of LV fractional shortening (FS) (FS [%] = [(EDD -ESD)/EDD] × 100) were calculated. Echocardiography of mice subjected to transverse aortic constriction is described in the "Transverse aortic constriction" section.
Histology. Hearts of 3-month-old transgenic and control animals (both sexes were used, with a similar male/female ratio in each genotype group; the number of animals is indicated in the figure legends) were fixed in 4% formaldehyde in PBS and embedded in paraffin blocks. Tissue sections were processed using standard histological methods. For the evaluation of fibrosis, Masson's trichrome analysis was performed (Bio-Optica Milano SpA). Figure 4c,d, Supplementary Figure 11 and Supplementary Table 1b was performed in the Mouse Cardiovascular Phenotyping Core of the Cardiovascular Division of the Washington University School of Medicine, as described in ref. 42 . Briefly, 4-month-old male WT and Krt18 −/− mice (n = 7 and n = 8 mice, respectively; 129SV and 129SV/mixed background, respectively) were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg) administered i.p., and surgery was performed using aseptic technique. Each mouse was restrained supine on a magnetic stainless steel surgical board with warmer attached. Following blunt dissection through the intercostal muscles, npg the aorta was identified and freed by additional blunt dissection. 7-0 silk suture was placed around the transverse aorta and tied tightly around a blunt needle (27 gauge). The needle was then rapidly removed and the chest wall was closed using a purse string suture. The surgical incision was closed in two layers with an interrupted suture pattern. The mouse was kept warm on a heating pad throughout the procedure and during recovery. At 4 or 8 weeks after the surgery, cardiac function was assessed by echocardiography.
Transverse aortic constriction (TAC). TAC surgery for the experiments shown in
Ultrasound examination was performed using a Vevo 2100 Ultrasound System (VisualSonics, Inc., Toronto, Ontario, Canada). Mice were lightly anesthetized with an i.p. injection of 0.005 ml/g of 2% Avertin (2,2,2-Tribromoethanol, SigmaAldrich, St. Louis, MO). Two-dimensional and Doppler images were obtained by hand-held manipulation of the ultrasound transducer. The measurements were carried out by a sonographer who was blinded to mouse genotype. Complete 2D long-axis and short-axis views of the LV and Doppler ultrasound examination of the TAC gradient were performed using multiple views. Non-invasive evaluation of the pressure gradient across TAC was performed by Doppler echocardiography. The aortic arch along with the surgically constricted transverse aorta were imaged from the right upper parasternal view. Pulse wave Doppler sample volume was placed at the site of the constriction, and aortic flow velocity was also measured proximal to the constriction at the level of the aortic root. Velocity time integral (VTI), mean and peak gradients were measured. The ratio of distal VTI/proximal VTI was calculated as an index of TAC gradient across the band. Supplementary Table 1b summarizes the echocardiography results and the number of mice used in the study. One of the Krt18 −/− mice died within the first 2 weeks after surgery, and another Krt18 −/− mouse was excluded by the analysis due to low peak velocity (1.05 and 1.1 mm/s, 2-and 4-weeks post-TAC, respectively) after surgery. Only mice subjected to TAC that had peak velocity of ≥3 mm/s were included in the post-TAC analyses.
Electron microscopy and immunogold labeling. Electron microscopy and immunoelectron microscopy protocols were essentially as previously described 26, 43 and performed at the German Cancer Research Center (DKFZ) in Heidelberg. For conventional electron microscopy, samples of heart tissue from mice (both sexes were used, with a similar male/female ratio in each genotype group; the number of animals is indicated in the figure legends) were cut into small pieces, briefly rinsed in PBS and fixed for 20 min at room temperature (RT) in 2.5% glutaraldehyde in 50 mM sodium cacodylate buffer (pH 7.2) containing 50 mM KCl and 2.5 mM MgCl 2 . After several washes in the same buffer, post-fixation was performed with 2% OsO 4 in cacodylate buffer for 2 h on ice, followed by several washes in distilled water and heavy metal staining (0.5% uranylacetate in distilled water) overnight at 4 °C. After three washes in water, samples were dehydrated in an ethanol series and in propylenoxide before embedding in Epon. Ultrathin sections (Reichert-Jung microtome, Ultracut, Leica) were stained with 2% uranylacetate in methanol for 15 min, followed by washes and final treatment with lead citrate in distilled water for 5 min. Electron microscopy images presented in Supplementary  Figure 4f were obtained using another protocol from a different facility (College of Medicine, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Illinois, USA) as described previously 13 .
Transmission electron microscopy of isolated mitochondria was performed at the electron microscopy facility of the University of Padova, Italy. Isolated cardiac mitochondria from mice of the indicated genotypes were fixed with 1.25% (V/V) glutaraldehyde in 0.1 M Na-cacodylate pH 7.4 for 1 h at room temperature. Then, mitochondria were centrifuged at 12,000g for 5 min at 4 °C and kept in 0.1 M Na-cacodylate buffer until sample processing for transmission electron microscopy following standard protocols.
For immunoelectron microscopy, cryostat sections of mouse hearts were fixed in PBS containing 2% formaldehyde for 5-7 min and permeabilized with PBS containing 0.1% saponin (3-5 min), followed by incubation with primary antibodies for at least 2 h. The antibodies used were anti-keratin 8 (Troma-I, DSHB, Developmental Studies Hybridoma Bank, University of Iowa, 1:50) and anti-desmoplakin (cat.# 65146, Progen Biotechnik, undiluted). After three washing steps, the samples were incubated with secondary antibodies conjugated with 1.4-nm gold particles (Nanogold, Biotrend) for 4 h. Samples were then post-fixed for 15 min at room temperature with 2.5% glutaraldehyde in sodium cacodylate buffer, briefly rinsed in the same buffer and twice incubated in buffer containing 200 mM sucrose and 50 mM HEPES (pH 5.8) for 10 min. This was followed by silver enhancement (Nanoprobes) for 7 to 10 min, two washes in 250 mM sodium thiosulfate, buffered with 50 mM HEPES (pH 5.8; 5 min each), and two short washes in distilled water. After post-fixation with 0.2% OsO 4 in cacodylate buffer for 30 min on ice, samples were dehydrated, embedded in Epon, sectioned and stained as described above. Electron micrographs were taken at 80 kV, using an EM 900 (Carl Zeiss). In some cases, images were further processed (level adjustment tool) using Photoshop CS3 version 10.0 (Adobe), without altering the results.
Mitochondria isolation from mouse hearts. Mouse hearts from the indicated genotypes (both sexes were used, with a similar male/female ratio in each genotype group; the number of animals is indicated in the figure legends and in Supplementary Fig. 5a ) were removed, weighed and minced in homogenization buffer (HB: 0.075 M sucrose, 0.225 M sorbitol, 1 mM EGTA, 0.1% fatty acid-free bovine serum albumin (BSA), 10 mM Tris-HCl, pH 7.4) (10 ml/g tissue). Heart tissue was homogenized in a glass Potter-Elvehjem homogenizer with a motor-driven Teflon pestle at 1,200 r.p.m., 8 strokes on ice. After a first centrifugation at 1,000g, 5 min, supernatants were collected and again centrifuged at 12,000g, 10 min. Then pellets were resuspended in HB and centrifuged at 13,000 r.p.m. for 2 min, and this step was repeated twice. Finally, the pellet was resuspended in 1 ml of MAITE buffer (100 mM KCl, 75 mM sorbitol, 25 mM sucrose, 10 mM Tris-HCl (pH 7.4), 10 mM K 2 HPO 4 , 5 mM MgCl 2 , 0.05 mM EDTA, 1 mg/ml BSA, pH 7.4) and centrifuged at 13,000 r.p.m. for 2 min. The mitochondria pellet was resuspended in 100 µl of experimental buffer (EB: 137 mM KCl, 10 mM Tris-MOPS, 2 mM KH 2 PO 4 , 20 mM EGTATris). All procedures were performed at 4 °C. Mitochondrial protein was quantified by the Bradford colorimetric assay.
Mitochondrial oxygen consumption. Cardiac mitochondria (150 µg), isolated as described in "Mitochondria isolation from mouse hearts," were incubated in 300 µl experimental buffer (EB: 137 mM KCl, 10 mM Tris-MOPS, 2 mM KH 2 PO 4 , 20 µM EGTA-Tris) supplemented with 5 mM glutamate and 2.5 mM malate. Oxygen consumption was measured with an Oxytherm System (Hansatech Instruments) equipped with a Clark-type electrode chamber. Basal O 2 consumption was recorded and after 3 min 400 µM ADP (state III) was added, followed 3 min later by 1 µM oligomycin (state IV).
Glutathione measurements. Cardiac mitochondria (200 µg), isolated as described in "Mitochondria isolation from mouse hearts, " were resuspended in 50 µl 1% (w/v) sulfosalicylic acid (SSA). After centrifugation at 12,000g, 4 °C, the supernatants were kept at −80 °C until determination of glutathione levels, as described in ref. 44 . Briefly, total glutathione (GSx) was measured by incubating 10 µl of sample (diluted in 90 µl water) in 100 µl reaction buffer containing 0.1 M sodium phosphate buffer pH 7.5, 1 mM EDTA, 0.4 mM NADPH, 0.3 mM 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), and glutathione reductase (1 U/ml) (cat.# G3664, Sigma-Aldrich). Absorbance was recorded at 405 nm every 30 s in parallel with GSSG standards. The slope values of the samples were extrapolated to the standard curve. To obtain the GSSG levels, 1 µl of 2-vinylpyridine was added to 26 µl of sample plus 0.2 M Tris (40 µl) and left for 1h at 4 °C. GSSG levels were measured as described for GSx levels; in parallel, GSSG standards were treated in the same way. GSH levels were calculated applying the formula GSX = GSH + (2 × GSSG).
Pyridine nucleotide extraction and measurement. Pyridine nucleotides were extracted from mitochondria (400 µg) isolated from hearts (as described in "Mitochondria isolation from mouse hearts") using 100 µl 0.1 M KOH (for NADH) or 0.1 M HCl (for NAD + ) in ethanol:water (1:1). After 20 min on ice, samples were centrifuged at 20,000g, 4 °C, and supernatants were kept at −80 °C until quantification. Measurements were carried out by reading absorbance at 360 nm with a PerkinElmer spectrophotometer. Samples (20 µl) were added to 480 µl buffer containing 100 mM HEPES-KOH (pH 8.0), 10 mM lactate (for NAD + measurements) or 4 mM Na-pyruvate (for NADH measurements) and 20 units/ml lactate dehydrogenase (cat.# L2500, Sigma-Aldrich). Changes in absorbance × min −1 were interpolated to standard curves prepared with known concentrations of NADH or NAD + . npg promoter NF-κB site from the human interferon-β gene, cloned in the same reporter plasmid 54 (TKluc, generated using the pGL3-Basic luciferase reporter vector (Promega)), was used in the studies.
Luciferase reporter assays were performed with HEK293 cells (ATCC), which were tested for mycoplasma contamination. Cells cultured in DMEM containing 10% FBS were generally seeded in 24-well plates and transfected by the polyethylenimine (PEI) method with a reporter vector (0.1 µg); an effector plasmid CMV-p65 (ref. 54) (0.5 µg) expressing p65 or an empty vector (pBluescript SK, Stratagene, Agilent Technologies); and a CMV-β-Gal vector 54 (0.2 µg) expressing β-galactosidase gene for normalization, as described in the text. After 48 h, the cells were washed and lysed using reporter lysis buffer (Promega). Luciferase and β-galactosidase activity assays were performed as previously described 55 . All experiments were done in triplicate or duplicate at least five times, and statistical analysis was performed as described in the figure legends.
Evans blue staining. To assess the impairment of sarcolemmal membrane integrity indicating cell necrosis, fluorescent staining with Evans blue dye (EBD) was used. Four-month-old mice (both sexes were used, with a similar male/female ratio in each genotype group; the number of animals is indicated in the figure legends) were injected with EBD (20 mg/ml in PBS) i.p. at a final concentration of 0.25 mg per 10 g of body weight. 24 h later, hearts were excised and embedded in OCT (Becton Dickinson) and snap-frozen in liquid nitrogen. Tissue sections of 10 µm in thickness were prepared and analyzed by fluorescence microscopy. Areas of red auto-fluorescence (EBD positive areas) were visualized at 594 nm excitation length. At least five images per section were processed and indicative images per genotype were selected.
